Especialidades y enfermedades  

Farmacéuticas. 19 de marzo de 2018

Pricing system reform and generics trend apparent at CPhI Japan 2018

Amsterdam, 19 March 2018: Increased international generic API companies and suppliers are reported at next month’s CPhI Japan 2018, traditionally an innovative drug focussed market, due to recent changes in the country. As uncovered earlier this year in the CPhI Japan 2018 report, after years of gradual reforms, the Japanese pharma economy is becoming extremely welcoming for generics and overseas manufactures – particularly those that can combine exemplary regulatory records with competitive pricing. By joining the Pharmaceutical Convention Inspection (PIC/S) scheme in 2014, Japan has opened its doors to new entrants.
Farmacéuticas. 28 de febrero de 2018

International investor influx in South East Asia

ASEAN Economic Community and relaxed rules on foreign ownership driving increases in international investment and partnerships
Farmacéuticas. 27 de febrero de 2018

Pertinax Pharma further expands into global woundcare markets with appointment of Business Development Manager

27 February 2018:Pertinax Pharma announces that Paul Williams has been appointed to the role of Business Development Manager. The new position, which will bolster the company’s commercial team, forms an integral part of the business strategy to secure expansion primarily by growing revenues from the international woundcare sector.
Farmacéuticas. 26 de febrero de 2018

Clintec International Expands Capabilities with the Accreditation of the Latest Generation of Medidata Rave EDC

London, United Kingdom, February 26th, 2018: Clintec International, an award winning, global Clinical Research Organisation (CRO), enhances its data management capabilities to include Medidata’s (NASDAQ: MDSO) latest generation of RAVE EDC (electronic data capture) to ensure superior operational efficiency and advanced functionality.
Farmacéuticas. 22 de febrero de 2018

WuXi STA and Regulus Announce microRNA Development and Manufacturing Collaboration

Agreement follows the recent opening of WuXi STA's oligonucleotide R&D labs in China and the USA
Farmacéuticas. 21 de febrero de 2018

Envigo appoints Lynn Lewis as Senior Vice President of Global Sales

East Millstone, NJ, February 21, 2018 – Envigo, a leading provider of nonclinical contract research services and research models, today announced the appointment of Lynn Lewis to the position of Senior Vice President, Global Sales. She brings extensive knowledge in both science and business to the company through her successful career in pharmaceuticals and leadership roles within sales and operations in the contract research organization (CRO) industry. This new role was created to strengthen the company’s position in the marketplace with a focus on continuing to provide outstanding customer service. Lynn will report to Craig Boyd, Envigo’s Chief Commercial Officer.
Farmacéuticas. 12 de febrero de 2018

ADC Bio developing downstream bioconjugation process

New manufacturing paradigm will save 25% of total costs and Specialist Process Innovation Group created to validate approach
Farmacéuticas. 08 de febrero de 2018

Pharmapack Europe Award Winners 2018: 21 years dedicated to the industry’s biggest innovations

BIOCORP, West Pharmaceutical Services, Inc. & sfm medical devices GmbH win prestigious ‘Exhibitor Innovation’   UCB Pharma, GSK Consumer Health & Virbac awarded ‘Health Product’


Subir notas de prensa y convocatorias

Próximas convocatorias   

Ver todas


Busca notas de prensa por especialidad médica o enfermedad.

Ver todas


Busca notas de prensa por su fecha de edición.

  Selecciona el año

Copyright © 2018, Farmavet, S.L. Todos los derechos reservados.